Fact Based List:
Sydney Rubin: Five Measures to Cope With The Pharmaceutical Side Effects Of Health Reform
Submitted by Anonymous on Thu, 10/09/2014 - 11:09
- Identify products that are potential targets for cost sharing, including new and specialty medicines
- Reach out to patient groups and high-profile patient bloggers to begin discussion on patient perspectives, wants and needs
- Provide clear and compelling educational materials to organizations that help demonstrate a medicine’s value
- Where ACA safeguards are insufficient, product suppliers should consider advocating for additional state or federal policy interventions
- Assume that external and internal communications are visible to payers and make sure all communications around a drug’s value are consistent and aligned
Source: Pharm Exec.
Source URL: http://blog.pharmexec.com/2014/10/03/coping-with-the-side-ef...
List Ratings: |
Lists You Might Also Be Interested In
- Top Five Specialty Pharmacy Companies by Specialty Drug Revenue
- Healthcare Global: 10 Most Innovative Pharma Companies to Watch in 2015
- USA Today: 5 reasons why Target sold pharmacy biz to CVS
- Top therapeutic areas (TAs) expected to drive biopharma market growth, 2022-2028
- Drug Channels: Top 4 Retail Pharmacy Chain Participation in 2018 Part D Preferred Pharmacy Networks
Login or register to post comments